Mangoceuticals, Inc.

US$0.19As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MGRXHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (71.06%)
Div yield —
ROE (95.10%)
Health Information Services
Beta (5Y) 2.15
PE TTM —
TSR TTM (90.63%)
Mkt cap US$4.332M
ROIC (50.33%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.236
20.89%
(57.69%)
Hold 12|7|8|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
3.10%
13.86%
14.09%
22.86%
Revenue$M
0.209
0.218
0.224
0.233
(2.76%)
3.93%
8.28%
9.96%
Peers (US$4.332M)
Cap (US$)
PE
4.785M
—
4.326M
—
Capital
TTM
5Y
10Y
Leveragex
1.127
0.268
0.193
EBIT/Intx
0.808
0.757
0.773
Own earn%
(67.46)
43.87
46.26
Sh yield%
24.91
48.06
50.40
Owners
Insiders/Inst%
6.71
36.79
Short interest%
3.78
SBC / revenue%
0.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
22–29
$1 testx
−0.2
Incr. ROIC%
7